BioNTech SE ADR (BNTX) Social Stream
BioNTech SE (BNTX) Price Targets From Analysts
Use the tables below to see what analysts covering BioNTech SE think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $450 | $146 | $275.666 | $174.78 | 57.72% |
| 2021-11-29 | 6 | $450 | $146 | $278.666 | $174.78 | 59.44% |
| 2021-12-15 | 6 | $450 | $146 | $279.555 | $174.78 | 59.95% |
| 2021-12-16 | 7 | $450 | $146 | $281 | $174.78 | 60.77% |
| 2022-01-11 | 7 | $450 | $146 | $281.6 | $174.78 | 61.12% |
| 2022-01-18 | 7 | $450 | $146 | $280.6 | $174.78 | 60.54% |
| 2022-01-26 | 7 | $450 | $146 | $274 | $174.78 | 56.77% |
| 2022-02-14 | 7 | $450 | $146 | $267.3 | $174.78 | 52.94% |
| 2022-03-18 | 7 | $450 | $146 | $264.6 | $174.78 | 51.39% |
The Trend in the Analyst Price Target
BNTX's average price target has moved up $180.35 over the prior 16 months.
BNTX reports an average of 30.63% for its upside potential over the past 129 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-29 | 6 | 450 | 146 | 278.666 | 362.52 | -23.13% |
| 2021-12-08 | 6 | 450 | 146 | 279.555 | 291.94 | -4.24% |
| 2022-01-11 | 7 | 450 | 146 | 281.600 | 215.80 | 30.49% |
| 2022-01-18 | 7 | 450 | 146 | 280.600 | 169.23 | 65.81% |
| 2022-03-14 | 7 | 450 | 146 | 264.600 | 151.92 | 74.17% |
BNTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.71 | 1 | 0 | 6 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 24 months, BNTX's average broker recommendation rating worsened by 0.71.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BNTX as an investment opportunity.
- BioNTech SE's variance in analysts' estimates is lower than -747.34% of all US stocks.
- BNTX has a higher average analyst price target than 838.29% of all US stocks.
- BioNTech SE's number of analysts covering the stock is greater than 129.06% of stocks in the large market cap category.
- In terms of how BioNTech SE fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 738.19% of that group.
In the Pharmaceutical Products industry, BLUE, BIIB, and ARGX are the three stocks most similar to BioNTech SE regarding the price target and analyst recommendation information presented here.
What is the outlook for BNTX? Use POWR Ratings for clearer insight into price direction.